NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

Contract summary

Industry

• Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£624,000,000

Procurement reference

CF-1932200D0O000000rwimUAA

Published date

27 October 2023

Closing date

1 December 2023

Closing time

1pm

Contract start date

1 April 2024

Contract end date

31 March 2028

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

---

Description

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Tender Reference: CM/PHR/22/5686/01

Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

---

More information

Attachments

• Document No. 04f - Labelling and Packaging of Unlicensed Medicines (Specials) - Best Practice Guidance for the NHS - December 2021.pdf
• Document No. 04f - Labelling and Packaging of Unlicensed Medicines (Specials) - Best Practice Guidance for the NHS - December 2021

• Document No. 07a - Aseptically Prepared Specials and Manufacturing Assessments.xlsx
• Document No. 07a - Aseptically Prepared Specials and Manufacturing Assessments

• Document No. 04a - Conformance Specification.doc
• Document No. 04a - Conformance Specification

• Document No. 04e - Management of Supply Issues.pdf
• Document No. 04e - Management of Supply Issues

• Document No. 04g - Standard Protocol for Deriving and Assessment of Stability Part 1 Aseptic Preparations (Small Molecules).pdf
• Document No. 04g - Standard Protocol for Deriving and Assessment of Stability Part 1 Aseptic Preparations (Small Molecules)

• Document No. 01 - Invitation to offer covering letter 5686.docx
• Document No. 01 - Invitation to offer covering letter 5686

• Document No. 02 - Terms of offer.docx
• Document No. 02 - Terms of offer

• Document No. 03 - Framework Agreement and Terms and Conditions.docx
• Document No. 03 - Framework Agreement and Terms and Conditions

• Document No. 04b - Performance Specification.doc
• Document No. 04b - Performance Specification

• Document No. 04c - Management Information - Template.xlsx
• Document No. 04c - Management Information - Template

• Document No. 04d - KPI Reporting Tool.xlsx
• Document No. 04d - KPI Reporting Tool

• Document No. 05 - Offer Schedule.xlsx
• Document No. 05 - Offer Schedule

• Document No. 07b - Basket of Goods.xlsx
• Document No. 07b - Basket of Goods

• Document No. 09 - Participating Authorities.xls
• Document No. 09 - Participating Authorities

• Document No. 04h - Standard Protocol for Deriving and Assessment of Stability Part 2 Biopharmaceuticals.pdf
• Document No. 04h - Standard Protocol for Deriving and Assessment of Stability Part 2 Biopharmaceuticals

• Document No. 04j - Protocols for the Integrity Testing of Syringes.pdf
• Document No. 04j - Protocols for the Integrity Testing of Syringes

• Document No. 06b - Call-Off Order Form.docx
• Document No. 06b - Call-Off Order Form

• Document No. 08 - Confidential information schedule.xls
• Document No. 08 - Confidential information schedule

• Document No. 06 - Form of offer.doc
• Document No. 06 - Form of offer

• Document No. 06a - Call-Off Award Procedure.doc
• Document No. 06a - Call-Off Award Procedure

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

---

About the buyer

Contact name

Collette Patrick

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
GB

Email

collette.patrick@nhs.net